A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

December 28, 2023

Study Completion Date

December 28, 2023

Conditions
Hypertension
Interventions
DRUG

TAK-536

TAK-536 granule formulation

Trial Locations (19)

Unknown

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya

Aichi Children's Health and Medical Center, Ōbu

Hyogo Prefectural Kobe Children's Hospital, Kobe

National Hospital Organization Kanazawa Medical Center, Kanazawa

Kitasato University Hospital, Sagamihara

Miyagi Children's Hospital, Sendai

Tohoku University Hospital, Sendai

University of the Ryukyus Hospital, Nakagami-gun

Okinawa Prefectural Nanbu Medical Center & Children's Medical Center, Shimajiri-gun

Osaka University Hospital, Suita

Shiga University of Medical Science Hospital, Ōtsu

Jichi Medical University Hospital, Shimotsuke

Tokyo Metropolitan Hospital Organization Tokyo Metropolitan Children's Medical Center, Fuchū

National Center for Child Health and Development, Setagaya-ku

Tokyo Women's Medical University Hospital, Shinjuku-ku

Hiroshima Prefectural Hospital, Hiroshima

Local Independent Administrative Institution Saitama prefectural hospital organization Saitama Children's Medical Center, Saitama

Shizuoka Childrens Hospital, Shizuoka

Wakayama Medical University Hospital, Wakayama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY